legislation: 114-hr-6174

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id	congress	bill_type	bill_number	title	policy_area	introduced_date	latest_action_date	latest_action_text	origin_chamber	sponsor_name	sponsor_state	sponsor_party	sponsor_bioguide_id	cosponsor_count	summary_text	update_date	url
114-hr-6174	114	hr	6174	Closing Loopholes for Orphan Drugs Act	Health	2016-09-27	2016-09-27	Referred to the House Committee on Energy and Commerce.	House	Rep. Welch, Peter [D-VT-At Large]	VT	D	W000800	2	Closing Loopholes for Orphan Drugs Act This bill amends the Public Health Service Act to revise the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program.	2023-01-11T13:33:43Z

Links from other tables

3 rows from bill_id in legislation_actions
4 rows from bill_id in legislation_subjects
2 rows from bill_id in legislation_cosponsors
0 rows from bill_id in cbo_cost_estimates